雪榕生物：预计2025年净利润2900万元—4000万元 同比扭亏

Core Viewpoint - Xuerong Bio (300511) expects a significant turnaround in its financial performance, projecting a net profit of 29 million to 40 million yuan for 2025, compared to a loss of 617 million yuan in the same period last year [1] Group 1: Financial Performance - The company anticipates a net profit of 29 million to 40 million yuan for 2025 [1] - In the previous year, the company reported a loss of 617 million yuan [1] Group 2: Industry Outlook - The edible mushroom industry is expected to stabilize and recover in the second half of 2025, leading to an increase in product prices [1] - The improvement in product prices is expected to enhance the company's gross margin [1] Group 3: Company Developments - Xuerong Bio has made breakthrough progress with a new strain of white enoki mushrooms, leveraging its seed source advantages [1] - The company has significantly increased its capacity utilization and reduced overall costs as a result of these advancements [1]